StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)

Close on Nov 17, 2026Market cap $3.00BP/E –Yield –

Telix Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for Telix Pharmaceuticals

Telix Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Telix Pharmaceuticals figures

See a number that looks wrong?